Sitagliptin and Hallucinations - a phase IV clinical study of FDA data

Summary:

Hallucinations is reported as a side effect among people who take Sitagliptin (sitagliptin), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Metformin, and have Stroke.

The phase IV clinical study analyzes which people have Hallucinations when taking Sitagliptin. It is created by eHealthMe based on reports of 3,929 people who have side effects when taking Sitagliptin from the FDA, and is updated regularly.

What is Sitagliptin?

Sitagliptin has active ingredients of sitagliptin. eHealthMe is studying from 3,933 Sitagliptin users. Check the latest studies of Sitagliptin.

What is Hallucinations?

Hallucinations (sensations that appear real but are created by your mind) is found to be associated with 1,896 drugs and 2,724 conditions by eHealthMe. Check the latest studies of Hallucinations.

On Jul, 11, 2026

3,929 people reported to have side effects when taking Sitagliptin.
Among them, 61 people (1.55%) have Hallucinations.

Among these 61 people:

How long have people been on Sitagliptin when they have Hallucinations? *

What is the gender of people who have Hallucinations when taking Sitagliptin? *

female: 79.63 %
male: 20.37 %

What is the age of people who have Hallucinations when taking Sitagliptin? *

What are other drugs people take besides Sitagliptin? *

What are other side effects people have besides Hallucinations? *

Arrhythmias (irregular heartbeat): 54 people, 88.52%
Nausea And Vomiting: 49 people, 80.33%
Fever: 49 people, 80.33%
Stress And Anxiety: 48 people, 78.69%
Heart Rate Increased: 47 people, 77.05%
Eye Pruritus (eye itching): 47 people, 77.05%
Facial Pain: 47 people, 77.05%
Fatigue (feeling of tiredness): 47 people, 77.05%
Feeling Abnormal: 47 people, 77.05%
Hair Loss: 47 people, 77.05%

What are the existing conditions these people have? *

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 45 people, 73.77%
Reflux Laryngitis (voice disorder caused by backflow of stomach fluids to the throat and voice box area): 43 people, 70.49%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 41 people, 67.21%
Ill-Defined Disorder: 41 people, 67.21%
Blood Pressure Abnormal: 36 people, 59.02%
Diabetes: 32 people, 52.46%
Adverse Drug Reaction: 15 people, 24.59%
High Blood Pressure: 2 people, 3.28%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 3.28%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 1.64%

* Approximation only. Some reports may have incomplete information.

Do you take Sitagliptin and have Hallucinations?

- Check whether Hallucinations is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sitagliptin:

Sitagliptin (3,933 reports)

Hallucinations treatments and more:

Hallucinations (98,683 reports)

Browse all side effects of Sitagliptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hallucinations:

Hallucinations (1,896 drugs)

Browse all the conditions that are associated with Hallucinations:

Hallucinations (2,724 conditions)

Related publications that referenced our studies

Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
Boschee T, DO PGY II, "Acute Hallucinations: Where Did That Come From?", , 2007 Jan .
Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
Boschee T, DO PGY II, "Acute Hallucinations: Where Did That Come From?", , 2007 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on sitagliptin (the active ingredients of Sitagliptin) and Sitagliptin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.